AlphaMol received milestone payments from both Shanghai Pharma and Salubris Pharma
Recently, AlphaMol received milestone payments from both Shanghai Pharma and Salubris Pharma for the co-developing orphan GPCR drug discovery pipeline.
Read moreRecently, AlphaMol received milestone payments from both Shanghai Pharma and Salubris Pharma for the co-developing orphan GPCR drug discovery pipeline.
Read moreAlphaMol attended BioEuro 2022 in Leipzig, Germany and made collaborations with different partners.
Read more
© 2023 All rights are reserved by AlphaMol Science Ltd